Skip to main content
SpringerLink
Log in

Nivolumab/Ipilimumab-Therapie des malignen Pleuramesothelioms

Doppelte Checkpointblockade beim MPM

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Vogelzang NJ et al. J Clin Oncol. 2003;21(14):2636-44

  2. Baas P et al. Lancet. 2021;397(10272):375-86

  3. Scherpereel A et al. Lancet Oncol. 2019;20(2):239-53

  4. de Gooijer CJ et al. Front Oncol. 2020;10:187

Download references

Author information

Authors and Affiliations

  1. FA für Onkologie, Lena-Christ-Str. 17, 82152, Planegg, Deutschland

    Andreas Schalhorn

Authors
  1. Andreas Schalhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schalhorn, A. Doppelte Checkpointblockade beim MPM. InFo Hämatol Onkol 24, 24–25 (2021). https://doi.org/10.1007/s15004-021-8617-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-021-8617-7

Search

Navigation